JCIA
Jackson Creek Investment Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $419K | Sell |
19,295
-9,989
| -34% | -$217K | 0.11% | 252 |
|
|
2025
Q1 | $710K | Sell |
29,284
-42,465
| -59% | -$1.03M | 0.23% | 202 |
|
|
2024
Q4 | $1.5M | Sell |
71,749
-2,220
| -3% | -$46.3K | 0.45% | 101 |
|
|
2024
Q3 | $1.47M | Buy |
+73,969
| New | +$1.47M | 0.44% | 123 |
|
|
2024
Q1 | – | Sell |
-68,203
| Closed | -$1.15M | – | 313 |
|
|
2023
Q4 | $1.15M | Sell |
68,203
-7
| -0% | -$118 | 0.44% | 56 |
|
|
2023
Q3 | $797K | Buy |
+68,210
| New | +$797K | 0.34% | 160 |
|
|
2023
Q2 | – | Sell |
-45,033
| Closed | -$747K | – | 316 |
|
|
2023
Q1 | $747K | Sell |
45,033
-24,300
| -35% | -$403K | 0.31% | 177 |
|
|
2022
Q4 | $1.29M | Sell |
69,333
-2,605
| -4% | -$48.5K | 0.57% | 8 |
|
|
2022
Q3 | $923K | Sell |
71,938
-55,565
| -44% | -$713K | 0.43% | 65 |
|
|
2022
Q2 | $1.31M | Sell |
127,503
-10,436
| -8% | -$107K | 0.53% | 12 |
|
|
2022
Q1 | $1.14M | Buy |
+137,939
| New | +$1.14M | 0.42% | 85 |
|